Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism

NCT02410824 is registered in ClinicalTrials.gov with CooperVision, Inc. as lead sponsor.

NCT NCT02410824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism
Lead sponsor
CooperVision, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
June 30, 2015
Enrollment
52 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

astigmatism